All-cause hepatocellular carcinoma survival in the era of direct-acting antiviral therapy.
Ian LockartBehzad HajarizadehNiamh BuckleyScott DavisonEmilia PrakosoMiriam T LevyJacob GeorgeGregory J DoreThomas BergPublished in: Journal of gastroenterology and hepatology (2021)
Hepatitis C virus-related HCC survival has increased in the DAA era, whereas adjusted survival remained stable for HBV-HCC and non-viral HCC.